Stockscreener 앱 받기
2.25
2.17%
-0.05
시간 외 거래:
2.37
0.12
+5.33%
전일 마감가:
$2.30
열려 있는:
$2.25
하루 거래량:
33,880
Relative Volume:
0.29
시가총액:
$5.38M
수익:
$3.91M
순이익/손실:
$-11.65M
주가수익비율:
-0.1826
EPS:
-12.3212
순현금흐름:
$-11.51M
1주 성능:
-4.26%
1개월 성능:
-43.89%
6개월 성능:
-61.90%
1년 성능:
-88.34%
1일 변동 폭
$2.25
$2.32
1주일 범위
$2.25
$2.46
52주 변동 폭
$2.24
$24.90
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
명칭
Intelligent Bio Solutions Inc
전화
646-790-5756
주소
135 W 41ST ST,, NEW YORK
Compare INBS vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
2.25 | 5.57M | 3.91M | -11.65M | -11.51M | -12.32 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Intelligent Bio Solutions Inc 주식(INBS)의 최신 뉴스
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Share Price, INBS Stock News, INBS Share Price & Updates - Kalkine
Intelligent Bio Solutions Inc. Financial Disclosures & SEC Filings - TradingView
INBS Q1 2025 Earnings: EPS Misses Estimates as Company Reports No RevenueProduct Revenue Analysis - newsline.com
INBS Q1 2025 Earnings: Earnings Miss Widens as Losses DeepenDividend Cut Risk - newsline.com
Intelligent Bio Solutions (INBS) Holds Near Support Amid Quiet Trading SessionMACD Signal Stocks - newsline.com
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference Over June 16-18 - 富途牛牛
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18 - marketscreener.com
Vegas microcap conference adds Intelligent Bio Solutions to lineup - Stock Titan
Intelligent Bio Solutions (INBS) Launches Study for Drug Screeni - GuruFocus
Intelligent Bio Solutions Launches Multi-Site Study for FDA 510(k) Clearance of Fingerprint Drug Screening System 1 - Minichart
Intelligent Bio Solutions Launches FDA Study for Codeine Test - TipRanks
Intelligent Bio Solutions starts FDA study for fingerprint drug test - Investing.com
Intelligent begins multi-site study to support FDA 510(k) for codeine screening - TradingView
Intelligent Bio Solutions (NASDAQ: INBS) launches multi-site 510(k) codeine drug screening study - Stock Titan
Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission - The Manila Times
Fingerprint drug test put in workers' hands in new U.S. study - Stock Titan
INBS Q1 2025 Earnings: EPS Misses Estimates Significantly, Stock Declines 3.5%Surprise Factor Analysis - newsline.com
Intelligent Bio Solutions (INBS) Edges Higher: Testing Key Resistance at $2.70Fundamental Weighted - newsline.com
INBS Q1 2025 Earnings: EPS Misses Estimates Significantly, Revenue Not Reported, Stock Rises 2.19%Earnings Weakness Phase - The Legal Advocate
Intelligent Bio Solutions (INBS) Climbs 4.4% as Shares Test Key Resistance Near $2.71Delta Hedging - newsline.com
INBS Q1 2025 Earnings: Wider-Than-Expected Loss as Revenue Remains AbsentShort-Term Outlook - newsline.com
Intelligent Bio Solutions (INBS) Surges 7% as Shares Rebound from Support LevelIntraday Trade Ideas - The Legal Advocate
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: Wider Loss Than Expected Weighs on SharesInstitutional Grade Picks - Newser
Intelligent Bio Solutions Inc. (INBS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: Wider-Than-Expected Loss Amid Continued Pre-Revenue StageTrending Entry Points - Newser
INBS|Intelligent Bio Solutions Inc|Price:2.530|Chg%:-0.10 - TradingKey
Intelligent Bio Solutions Company Profile & Introduction - Moomoo
Intelligent Bio Solutions 3Q Loss $2.87M >INBS - Moomoo
INBS - Finviz
[SCHEDULE 13G] INTELLIGENT BIO SOLUTIONS INC. Passive Investment Disclosure (>5%) - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Is Intelligent Bio Solutions (INBS) Undervalued After Q3 FY2026 - GuruFocus
Intelligent Bio Solutions (NASDAQ: INBS) grows Q3 revenue 46% with margins above 50% - Stock Titan
Intelligent Bio Reports Q3 Revenue Up 46%, Gross Margin Over 50% as Cartridge Sales Surge - TradingView
Intelligent Bio Solutions Inc. Q3 2026 10-Q Filing: Financial Statements, Reverse Stock Split, and Company Overview - Minichart
Intelligent Bio Solutions 3Q Loss/Shr $1.80 >INBS - Moomoo
Intelligent Bio Solutions Releases Q3 2026 Financial Results - AlphaStreet
Intelligent Bio Solutions Reports 46% Revenue Growth in Q3 FY202 - GuruFocus
Finger-scan drug test maker tops 50% margins as sales jump 46% - Stock Titan
Intelligent Bio Solutions Q3 revenue rises 46%, gross margin tops 50% - TradingView
INTELLIGENT BIO SOLUTIONS INC. 3Q 2026: Revenue $1.06M, Net loss $(2.86M) — 10-Q Summary - TradingView
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year - marketscreener.com
Intelligent Bio Solutions (NASDAQ: INBS) boosts revenue but warns on going concern - Stock Titan
Intelligent Bio Solutions Inc. Reports Unaudited Impairment of Long-Lived Assets for the Third Quarter Ended March 31, 2026 - marketscreener.com
TradingKey - TradingKey
INBS Q3'26 Earnings: EPS estimate is 1.40 USD - TradingView
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Intelligent Bio Solutions Inc (STU:12Q0) Stock Price & 30 Year Financial Data - GuruFocus
How Intelligent (INBS) is reshaping its industry (Trend Weakens) 2026-05-08Gap Down Stocks - newser.com
Intelligent Bio Solutions Inc (INBS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):